Cargando…

Mucosal microbiota and gene expression are associated with long-term remission after discontinuation of adalimumab in ulcerative colitis

Given that sustained remission is the ultimate treatment goal in the management of patients with ulcerative colitis (UC), the decision to stop anti-tumor necrosis factor (anti-TNF) treatment in UC patients is difficult. The aim of this study was to evaluate mucosal microbiota and gene expression pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakurai, Toshiharu, Nishiyama, Hiroki, Sakai, Kazuko, De Velasco, Marco A., Nagai, Tomoyuki, Komeda, Yoriaki, Kashida, Hiroshi, Okada, Akiyoshi, Kawai, Isao, Nishio, Kazuto, Ogata, Hiroyuki, Kudo, Masatoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644643/ https://www.ncbi.nlm.nih.gov/pubmed/33154436 http://dx.doi.org/10.1038/s41598-020-76175-2

Ejemplares similares

Refractory case of ulcerative colitis with idiopathic thrombocytopenic purpura successfully treated by Janus kinase inhibitor tofacitinib: A case report
por: Komeda, Yoriaki, et al.
Publicado: (2020)

A case of small invasive gastric cancer arising from Helicobacter pylori‐negative gastric mucosa: Fundic gland‐type adenocarcinoma
por: Komeda, Yoriaki, et al.
Publicado: (2017)

Integrative analysis of gut microbiome and host transcriptomes reveals associations between treatment outcomes and immunotherapy‐induced colitis
por: Sakurai, Toshiharu, et al.
Publicado: (2021)

Risk factors for local recurrence and appropriate surveillance interval after endoscopic resection
por: Komeda, Yoriaki, et al.
Publicado: (2019)

Castor oil as booster for colon capsule endoscopy preparation reduction: A prospective pilot study and patient questionnaire
por: Takashima, Kota, et al.
Publicado: (2021)

The oncoprotein gankyrin promotes the development of colitis-associated cancer through activation of STAT3
por: Sakurai, Toshiharu, et al.
Publicado: (2017)

Deficiency of Gankyrin in the small intestine is associated with augmented colitis accompanied by altered bacterial composition of intestinal microbiota
por: Sakurai, Toshiharu, et al.
Publicado: (2020)

Artificial intelligence-based endoscopic diagnosis of colorectal polyps using residual networks
por: Komeda, Yoriaki, et al.
Publicado: (2021)

Usefulness of Ustekinumab for Treating a Case of Myelodysplastic Syndrome-associated Inflammatory Bowel Disease
por: Kono, Masashi, et al.
Publicado: (2019)

Contribution of C1485T mutation in the HBx gene to human and murine hepatocarcinogenesis
por: Hagiwara, Satoru, et al.
Publicado: (2017)

Serum leucine‐rich alpha‐2 glycoprotein in monitoring disease activity and intestinal mucosal healing for biotherapy‐naïve cases with ulcerative colitis
por: Kono, Masashi, et al.
Publicado: (2023)

Intestinal Microbiota and Gene Expression Reveal Similarity and Dissimilarity Between Immune-Mediated Colitis and Ulcerative Colitis
por: Sakai, Kazuko, et al.
Publicado: (2021)

Cases with Refractory Ascites and a Delayed Response to Tolvaptan
por: Hagiwara, Satoru, et al.
Publicado: (2016)

Removal of diminutive colorectal polyps: A prospective randomized clinical trial between cold snare polypectomy and hot forceps biopsy
por: Komeda, Yoriaki, et al.
Publicado: (2017)

The prevalence of sessile serrated lesion in the colorectum and its relationship to synchronous colorectal advanced neoplasia: a systemic review and meta-analysis
por: Shiu, Sz-Iuan, et al.
Publicado: (2021)

Efficacy and Safety of Chemotherapy Following Anti-PD-1 Antibody Therapy for Gastric Cancer: A Case of Sclerosing Cholangitis
por: Kono, Masashi, et al.
Publicado: (2019)

Successful initial tofacitinib treatment for acute severe ulcerative colitis with steroid resistance: a case series
por: Komeda, Yoriaki, et al.
Publicado: (2023)

Long-Term Survival of More than 5 Years with Maintenance Therapy Using Single-Agent Pemetrexed in a Patient with Diffuse Malignant Peritoneal Mesothelioma
por: Otsuka, Yasuo, et al.
Publicado: (2023)

Purpura-free small intestinal IgA vasculitis complicated by cytomegalovirus reactivation
por: Matsumura, Mariko, et al.
Publicado: (2020)

A case of HCC successfully treated with infliximab‐steroid sequential therapy for small bowel perforation due to atezolizumab/bevacizumab combination therapy
por: Hagiwara, Satoru, et al.
Publicado: (2022)

Endoscopic submucosal dissection with reinforcement using a laparoscopic approach for a duodenal cavernous hemangioma
por: Masaki, Sho, et al.
Publicado: (2022)

Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study
por: Tanaka, Yoshiya, et al.
Publicado: (2015)

A Multicenter Prospective Validation Study on Selective Endoscopic Resection of Sessile Serrated Lesions Using Magnifying Colonoscopy in Clinical Practice
por: Hirata, Daizen, et al.
Publicado: (2023)

Correction: Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study
Publicado: (2016)

Erythropoietic Protoporphyria-related Hepatopathy Successfully Treated with Phlebotomy
por: Yoshida, Akihiro, et al.
Publicado: (2018)

Diagnosis of an intraductal papillary neoplasm of the bile duct with fibrovascular stalks using detective flow imaging
por: Omoto, Shunsuke, et al.
Publicado: (2023)

The “echo-free space” technique: a safe and reliable method for endoscopic ultrasound scope insertion
por: Omoto, Shunsuke, et al.
Publicado: (2023)

The First Case of Biological Therapy Discontinuation After a Complete Remission Induced by Maintenance Therapy With Adalimumab for Refractory Ulcerative Colitis
por: Tanida, Satoshi, et al.
Publicado: (2015)

Dysbiosis-Associated Polyposis of the Colon—Cap Polyposis
por: Okamoto, Kazuki, et al.
Publicado: (2018)

A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission
por: Chatzidionysiou, Katerina, et al.
Publicado: (2016)

Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational study
por: Hirata, Shintaro, et al.
Publicado: (2013)

Higher Adalimumab Trough Levels Are Associated with Histologic Remission and Mucosal Healing in Inflammatory Bowel Disease
por: Wong, Rochelle, et al.
Publicado: (2023)

Reversible proteinuria after adalimumab discontinuation in a patient with Crohn's disease
por: Katsanos, Konstantinos H., et al.
Publicado: (2010)

Utility of endoscopic ultrasound in hemorrhage from recurrent duodenal varices
por: Matsui, Shigenaga, et al.
Publicado: (2018)

Involvement of Heat Shock Protein A4/Apg-2 in Refractory Inflammatory Bowel Disease
por: Adachi, Teppei, et al.
Publicado: (2014)

Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
por: Kimura, Noriko, et al.
Publicado: (2019)

EMR is not inferior to ESD for early Barrett’s and EGJ neoplasia: An extensive review on outcome, recurrence and complication rates
por: Komeda, Yoriaki, et al.
Publicado: (2014)

Endoscopic treatment of tracheoesophageal fistula using the over-the-scope-clip system
por: Matsui, Shigenaga, et al.
Publicado: (2017)

Endoscopic submucosal dissection of duodenal adenocarcinoma arising from Brunner’s gland
por: Tanaka, Hidekazu, et al.
Publicado: (2019)

Adalimumab serum levels and antidrug antibodies towards adalimumab in peripheral spondyloarthritis: no association with clinical response to treatment or with disease relapse upon treatment discontinuation
por: Paramarta, Jacqueline E, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mtl1p4k8vbubkg9m26eees0u56